Your browser doesn't support javascript.
loading
Real-world evidence to advance knowledge in pulmonary hypertension: Status, challenges, and opportunities. A consensus statement from the Pulmonary Vascular Research Institute's Innovative Drug Development Initiative's Real-world Evidence Working Group.
Morland, Kellie; Gerges, Christian; Elwing, Jean; Visovatti, Scott H; Weatherald, Jason; Gillmeyer, Kari R; Sahay, Sandeep; Mathai, Stephen C; Boucly, Athénaïs; Williams, Paul G; Harikrishnan, Sivadasanpillai; Minty, Evan P; Hobohm, Lukas; Jose, Arun; Badagliacca, Roberto; Lau, Edmund M T; Jing, Zhi-Cheng; Vanderpool, Rebecca R; Fauvel, Charles; Leonidas Alves, Jose; Strange, Geoff; Pulido, Tomas; Qian, Junyan; Li, Mengtao; Mercurio, Valentina; Zelt, Jason G E; Moles, Victor M; Cirulis, Meghan M; Nikkho, Sylvia M; Benza, Raymond L; Elliott, C Gregory.
Afiliação
  • Morland K; Global Medical Affairs United Therapeutics Corporation Research Triangle Park North Carolina USA.
  • Gerges C; Department of Internal Medicine II, Division of Cardiology Medical University of Vienna Vienna Austria.
  • Elwing J; Division of Pulmonary, Critical Care, and Sleep Medicine University of Cincinnati Cincinnati Ohio USA.
  • Visovatti SH; Division of Cardiovascular Medicine The Ohio State University Columbus Ohio USA.
  • Weatherald J; Department of Medicine, Division of Pulmonary Medicine University of Alberta Edmonton Canada.
  • Gillmeyer KR; The Pulmonary Center Boston University Chobian & Avedisian School of Medicine Boston Massachusetts USA.
  • Sahay S; Center for Healthcare Organization & Implementation Research VA Bedford Healthcare System and VA Boston Healthcare System Bedford Massachusetts USA.
  • Mathai SC; Division of Pulmonary, Critical Care & Sleep Medicine Houston Methodist Hospital Houston Texas USA.
  • Boucly A; Division of Pulmonary and Critical Care Medicine Johns Hopkins University School of Medicine Baltimore Maryland USA.
  • Williams PG; Faculté de Médecine Université Paris-Saclay Le Kremlin-Bicêtre France.
  • Harikrishnan S; Service de Pneumologie et Soins Intensifs Respiratoires, Centre de Référence de l'Hypertension Pulmonaire, Hôpital Bicêtre Assistance Publique Hôpitaux de Paris Le Kremlin Bicêtre France.
  • Minty EP; National Heart and Lung Institute Imperial College London UK.
  • Hobohm L; Center of Chest Diseases & Critical Care Milpark Hospital Johannesburg South Africa.
  • Jose A; Sree Chitra Tirunal Institute for Medical Sciences and Technology Trivandrum Kerala India.
  • Badagliacca R; Department of Medicine & O'Brien Institute for Public Health University of Calgary Calgary Canada.
  • Lau EMT; Department of Cardiology University Medical Center of the Johannes Gutenberg University Mainz Mainz Germany.
  • Jing ZC; Center for Thrombosis and Hemostasis (CTH) University Medical Center of the Johannes Gutenberg University Mainz Mainz Germany.
  • Vanderpool RR; Division of Pulmonary, Critical Care, and Sleep Medicine University of Cincinnati Cincinnati Ohio USA.
  • Fauvel C; Department of Clinical, Anesthesiological and Cardiovascular Sciences, Sapienza University of Rome Policlinico Umberto I Rome Italy.
  • Leonidas Alves J; Department of Respiratory Medicine, Royal Prince Alfred Hospital University of Sydney Camperdown New South Wales Australia.
  • Strange G; Faculty of Medicine and Health University of Sydney Camperdown New South Wales Australia.
  • Pulido T; State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital Chinese Academy of Medical Sciences and Peking Union Medical College Beijing China.
  • Qian J; Division of Cardiovascular Medicine The Ohio State University Columbus Ohio USA.
  • Li M; Service de Cardiologie, Centre de Compétence en Hypertension Pulmonaire 27/76, Centre Hospitalier Universitaire Charles Nicolle, INSERM EnVI U1096 Université de Rouen Rouen France.
  • Mercurio V; Pulmonary Division, Heart Institute University of São Paulo Medical School São Paulo Brazil.
  • Zelt JGE; School of Medicine The University of Notre Dame Australia Perth Western Australia Australia.
  • Moles VM; Ignacio Chávez National Heart Institute México City Mexico.
  • Cirulis MM; Department of Rheumatology and Clinical Immunology, Chinese Academy of Medical Sciences & Peking Union Medical College, National Clinical Research Center for Dermatologic and Immunologic Diseases (NCRC-DID), Ministry of Science & Technology, State Key Laboratory of Complex Severe and Rare Di
  • Nikkho SM; Department of Rheumatology and Clinical Immunology, Chinese Academy of Medical Sciences & Peking Union Medical College, National Clinical Research Center for Dermatologic and Immunologic Diseases (NCRC-DID), Ministry of Science & Technology, State Key Laboratory of Complex Severe and Rare Di
  • Benza RL; Department of Translational Medical Sciences Federico II University Naples Italy.
  • Elliott CG; Department of Medicine, Faculty of Medicine University of Ottawa Ottawa Canada.
Pulm Circ ; 13(4): e12317, 2023 Oct.
Article em En | MEDLINE | ID: mdl-38144948
ABSTRACT
This manuscript on real-world evidence (RWE) in pulmonary hypertension (PH) incorporates the broad experience of members of the Pulmonary Vascular Research Institute's Innovative Drug Development Initiative Real-World Evidence Working Group. We aim to strengthen the research community's understanding of RWE in PH to facilitate clinical research advances and ultimately improve patient care. Herein, we review real-world data (RWD) sources, discuss challenges and opportunities when using RWD sources to study PH populations, and identify resources needed to support the generation of meaningful RWE for the global PH community.
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2023 Tipo de documento: Article